LGALS3 and neoplasm: Furthermore, Galectin-3 expressed by a variety of cells in the tumor microenvironment instead of the tumor itself may interact with LAG3 on tumor-specific CD8+ T cells, thus resulting in the modulation of anti-tumor immune responses (32).